Abstract
The traditional use of Hypericum perforatum L. (St. Johns wort, Clusiaceae) in Western medicine was well known even before the 1600s: St. Johns extracts were used to relieve various types of nervous disease long before depression was recognized as a well described pathology. Today, random controlled trials clearly confirm the efficacy of this plant extract over placebo in the treatment of mild to moderately severe depression. Of the different classes of H. perforatum secondary metabolites, the prenylated acylphloroglucinol hyperforin has emerged as key player for anti-depressant activity. But as well as Hypericums anti-depressant property, several other pharmacological actions have now been documented – examples include anti-bacterial, anti-proliferative and anti-inflammatory - many of which may be related to hyperforin. These findings add support to the effectiveness of St. Johns wort as a folk remedy in common use for treating skin injuries, burns and neuralgias. This review gives a historical overview of the plant, including its medical uses, plus a look at the chemical structure of the most relevant phyto-constituents. This is followed by a close analysis of recent data regarding the biological effects of hyperforin, focusing on antiinflammatory and anti-tumor activities. The compounds clear and proven actions qualify it as an interesting lead candidate for countering inflammatory disease and cancer.
Keywords: Hypericin, angiogenesis, Anthraquinonic derivatives, anti-depressant, HIV-1 genome
Current Bioactive Compounds
Title: The Renaissance of Hypericum perforatum: Bio-Medical Research Catches Up with Folk Medicine
Volume: 3 Issue: 2
Author(s): Isabella Dell'Aica, Spiridione Garbisa and Rosy Caniato
Affiliation:
Keywords: Hypericin, angiogenesis, Anthraquinonic derivatives, anti-depressant, HIV-1 genome
Abstract: The traditional use of Hypericum perforatum L. (St. Johns wort, Clusiaceae) in Western medicine was well known even before the 1600s: St. Johns extracts were used to relieve various types of nervous disease long before depression was recognized as a well described pathology. Today, random controlled trials clearly confirm the efficacy of this plant extract over placebo in the treatment of mild to moderately severe depression. Of the different classes of H. perforatum secondary metabolites, the prenylated acylphloroglucinol hyperforin has emerged as key player for anti-depressant activity. But as well as Hypericums anti-depressant property, several other pharmacological actions have now been documented – examples include anti-bacterial, anti-proliferative and anti-inflammatory - many of which may be related to hyperforin. These findings add support to the effectiveness of St. Johns wort as a folk remedy in common use for treating skin injuries, burns and neuralgias. This review gives a historical overview of the plant, including its medical uses, plus a look at the chemical structure of the most relevant phyto-constituents. This is followed by a close analysis of recent data regarding the biological effects of hyperforin, focusing on antiinflammatory and anti-tumor activities. The compounds clear and proven actions qualify it as an interesting lead candidate for countering inflammatory disease and cancer.
Export Options
About this article
Cite this article as:
Dell'Aica Isabella, Garbisa Spiridione and Caniato Rosy, The Renaissance of Hypericum perforatum: Bio-Medical Research Catches Up with Folk Medicine, Current Bioactive Compounds 2007; 3 (2) . https://dx.doi.org/10.2174/157340707780809644
DOI https://dx.doi.org/10.2174/157340707780809644 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acknowledgements to Reviewers
Current Medicinal Chemistry Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells
Mini-Reviews in Medicinal Chemistry Targeting Vascular Neural Network in Intracerebral Hemorrhage
Current Pharmaceutical Design Modulation of Apoptosis in Acute Ischemic Stroke as Treatment Challenges
Current Immunology Reviews (Discontinued) Benzopyran Derivatives as Cardio-selective ATP-sensitive Potassium Channel Openers: A Review
Mini-Reviews in Medicinal Chemistry Advances in Methods for Therapeutic Peptide Discovery, Design and Development
Current Pharmaceutical Biotechnology One-Pot Synthesis of (3-Phenylisoxazol-5-yl)methanol Derivatives Under Ultrasound
Letters in Organic Chemistry Natural and Synthetic Compounds with an Antimycobacterial Activity
Mini-Reviews in Organic Chemistry Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut
Current Protein & Peptide Science Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature
Current Drug Abuse Reviews Integrated Genomic Analysis Revealed Associated Genes for Alzheimer’s Disease in APOE4 Non-Carriers
Current Alzheimer Research Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects
Medicinal Chemistry Definition of Genes and Paths Involved in Alzheimers Disease: Using Gene Expression Profiles and Chemical Genetics at the Mouse Brain Level
Current Genomics Effects of an Acute Treatment with L-Thyroxine on Memory, Habituation, Danger Avoidance, and on Na+, K+-ATPase activity in Rat Brain
Current Neurovascular Research Theory of Mind in the Early Course of Schizophrenia
Current Psychiatry Reviews Preface
Central Nervous System Agents in Medicinal Chemistry Phenylbutyric Acid Protects Against Spatial Memory Deficits in a Model of Repeated Electroconvulsive Therapy
Current Neurovascular Research Untangling Alzheimer’s Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability – An Effort to Understand a Complex Disease
Current Alzheimer Research Enhanced Tolerance against Early and Late Apoptotic Oxidative Stress in Mammalian Neurons through Nicotinamidase and Sirtuin Mediated Pathways
Current Neurovascular Research